| 000 | 01490 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518051834.0 | ||
| 264 | 0 | _c20200106 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v25.i25.3136 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeureiter, Daniel | |
| 245 | 0 | 0 |
_aHepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cJul 2019 |
||
| 300 |
_a3136-3150 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Development |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStintzing, Sebastian | |
| 700 | 1 | _aKiesslich, Tobias | |
| 700 | 1 | _aOcker, Matthias | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 25 _gno. 25 _gp. 3136-3150 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v25.i25.3136 _zAvailable from publisher's website |
| 999 |
_c29928239 _d29928239 |
||